On December 18, 2023, under the guidance of the Guangzhou Municipal Science and Technology Bureau, co-sponsored by the Guangzhou Industrial Development Research Institute, the Guangzhou Science and Technology Innovation Enterprise Association, and PwC China, and co-organized by the Guangzhou Branch of China Construction Bank, the "2023 Discovery of Guangzhou Unicorn Innovative Enterprises" event successfully completed the selection of the list, and released the list of "Unicorn" innovative enterprises, "Future Unicorn" innovative enterprises, and "Seed Unicorn" enterprises in 2023. With its leading scientific research and innovation strength, strong product research and development capabilities, wide market recognition and broad development prospects in the field of biomedicine, Moon Biotech has successfully stood out in the new economy enterprise track and has been listed as an innovative enterprise of "Future Unicorn".
List of 2023 "Future Unicorn" Innovative Enterprises (excerpt).
*: Guangzhou Science and Technology Innovation Enterprise Association).
The "2023 Discovery of Guangzhou Unicorn Innovative Enterprises" activity has unearthed a number of local enterprises in the new economic track with strong innovation, fast growth and great development potential, so as to cultivate a new engine for the high-quality development of Guangzhou's new economy. Most of the innovative enterprises on this list have made breakthroughs in key core technologies, setting a benchmark for innovation of science and technology enterprises, and representing an important force leading industrial transformation in the new economic track.
As an international leading microbiome platform technology company, Moon Biotech has always taken forward-looking technology research and development as the core since its establishment 8 years ago, and has built a complete microbiome industrialization technology system from the discovery of microorganisms, screening microorganisms, modification of microorganisms to the application of microorganisms, and has established a highly competitive microbial strain bank in the world, discovering, preserving and identifying more than 250,000 microbial strains with independent intellectual property rights. The company's business covers two major sectors: biological agriculture and biomedicine: in terms of biological agriculture, as of the end of 2023, more than 70 microbial product certificates have been registered and are being registered, more than 40 patent applications have been submitted in 2023, and more than 20 agricultural microbial products have been listed, which have been highly recognized by the market, and have achieved rapid growth in performance for four consecutive yearsIn the biopharmaceutical sector, the company relies on the leading full-spectrum live bacteria drug development platform, aiming at the potential of microorganisms in the field of tumor immunity and metabolic diseases, and has three clinical drugs under development and multiple preclinical drug pipelines.
Being on the list of "Future Unicorn" innovative enterprises this time means that the current growth performance and future development potential of Moon Biotech have received the attention and affirmation of the market, professional institutions and the investment community, which is not only a full recognition of Moon Bio's R&D innovation, core competitiveness and industry demonstration role, but also an encouragement and spur for Moon Biotech to adhere to the innovation-driven layout of promising biological agriculture and biomedical industries.
Future Unicorn" Medal for Innovative Enterprises.
Hundreds of people compete for the stream, and those who strive are the first. In the future, Moon Biotech will give full play to the demonstration and leading role of "future unicorn" innovative enterprises, continue to increase R&D investment, continue to deepen technological innovation, give full play to the advantages of enterprise R&D and production technology, contribute to the power of leading industrial transformation, provide new momentum for the development of emerging industries in Guangzhou, and contribute to the high-quality development of China's bio-agriculture and pharmaceutical industries.
Appendix: List of "Future Unicorn" innovative enterprises in 2023
About Moon Biotech
Moon Biotech is an international leading microbiome platform technology company, which has built a complete microbiome industrialization technology system from the discovery of microorganisms, the screening of microorganisms, the modification of microorganisms to the application of microorganisms. The company has established the world's largest and most biodiverse strain resource bank, and has discovered, preserved and identified more than 250,000 microbial strains with independent intellectual property rights. On the basis of in-depth microbiome research and data mining, we provide high-throughput screening of biologically active functional microorganisms and their metabolites for urgent and critical social market needs (biomedicine, bioagriculture), and work with partners to provide customers with first-class microbial products and solutions.
Moon Bio
Creating a better future with microbes
Landline: 020-31603387
E-mail: info@moonbiocom
*：www.moonbio.com